Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging
Aging Cell · 2026-10 · 25 (10)
DOI: 10.1111/acel.70749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 02.10.2026. Verfasst von Hao-Lin Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China. Hauptthemen laut MEDLINE: Oocytes, Aging, Fertility. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, Open Competition Project of Guangxi Plateau Discipline of Youjiang Medical University for Nationalities.
Abstract (Originalsprache)
Aging represents a major contributor to the deterioration of female fertility, with oocyte quality being the central determinant of ovarian aging, a key factor underlying infertility. Although several natural compounds with anti‐aging activity have been documented, highly effective strategies to reverse ovarian aging remain elusive. Here, we report that the peptide elamipretide preserves ovarian function and sustains female fertility during maternal aging. We found that elamipretide administration increases litter size in aged mice and ameliorates oocyte quality decline. Metabolomic and transcriptomic profiling revealed substantial restoration of multiple biological processes in aged oocytes after elamipretide injection. Elamipretide improved both nuclear and cytoplasmic maturation of aged oocytes, accompanied by enhanced cytoskeletal dynamics, mitochondrial metabolism, and organelle reorganization. Mechanistically, elamipretide alleviated age‐associated oocyte maturation defects through synergistic activation of the vitamin B6–VEGF axis. Furthermore, elamipretide significantly promoted maturation, fertilization, and cleavage of aged human oocytes. Elamipretide treatment also rescued the developmental competence of porcine oocytes under oxidative damage. Collectively, this study identifies a novel peptide therapeutic candidate for aging‐related infertility, showing that elamipretide restores the quality of aged oocytes for fertility by coordinately boosting nuclear and cytoplasmic maturation via activation of the VEGF signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China.
- Center of Reproductive Medicine, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
- Guangxi Key Laboratory of Artificial Intelligence for Genetic Diseases of Long-Dwelling Nationalities, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
ORCID-Profile: Huanhua Chen, Shao-Chen Sun
Förderung
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Open Competition Project of Guangxi Plateau Discipline of Youjiang Medical University for Nationalities
Zitieren
APA
Zhang, H. L., Wang, Y., Wang, C., Guo, X., Chen, H., Hou, Y. X., Wu, X., Wu, Z. J., Pan, W. L., Ma, R. J., Lu, P. S., Shu, J., & Sun, S. C. (2026). Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging. Aging Cell, 25(10). https://doi.org/10.1111/acel.70749
Vancouver
Zhang HL, Wang Y, Wang C, Guo X, Chen H, Hou YX, et al. Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging. Aging Cell. 2026;25(10). doi:10.1111/acel.70749
BibTeX
@article{Zhang2026,
author = {Zhang, Hao-Lin and Wang, Yue and Wang, Caizhu and Guo, Xin and Chen, Huanhua and Hou, Yu-Xuan and Wu, Xuan and Wu, Zi-Jian and Pan, Wen-Lin and Ma, Rui-Jie and Lu, Ping-Shuang and Shu, Jinhui and Sun, Shao-Chen},
title = {Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {10},
doi = {10.1111/acel.70749}
}
EUVIMED